Metabolic and mechanic complications can be seen due to peritoneal dialysis. Pleuroperitoneal leakage is rare but can be a life-threatening mechanic complication of peritoneal dialysis. Some techniques have been used to diagnose this entity. Radionuclide imaging can be used as a reliable technique in order to show the pleuroperitoneal passage and can be used to show the recovery. Herein we present the first case report in the literature about a patient with pleuroperitoneal shunt that was demonstrated scintigraphically during the leakage and after the resolution.
INTRoDUcTIoN
CAPD or APD have been used as a renal replacement modality choice for a long time. Although some complications like peritonitis frequently complicate this procedure, some rare but life-threatening complications may also occur and sensitive diagnostic measures are needed to confirm them. Tc-99m DTPA scintigraphy can be used as a reliable technique for this purpose.
cASe RepoRT
A 54-year-old female with chronic renal failure due to polycystic kidney disease had been on continuous ambulatory peritoneal dialysis (CAPD) treatment for 10 years. As a consequence of coronary heart disease, she had undergone a coronary by-pass grafting operation and she was switched to hemodiafiltration for 3 days post-operatively. At the end of the 3rd day, CAPD treatment restarted. At the 10th day postoperatively, some amount of fluid was detected in the left thoracal cavity. Biochemical tests were done and the fluid was transudative as it had the same glucose concentration as serum. A pleurocath was placed and by the 12th day there was no fluid anymore. After a 2-month asymptomatic period, she presented to the nephrology clinic with a complaint of breathlessness. Her complaint had started about one week ago and had gradually increased. The postero-anterior chest X-ray showed increased density on the left side up to the 4th rib. Thoracentesis was performed and pleural fluid was obtained. On fluid analysis, adenosine deaminase and acid-resistant bacillus tests were negative, glucose concentration was 319 mg/dl, albumin was 0.3 g/ dl, total protein was 465 g/dl, LDH was 30 U/L and the concurrent serum glucose was 102 mg/dl, albumin was 3.0 g/dl, LDH was 197 U/L, and total protein was 5.7 g/dl. The cell count in the fluid was 96/mm space was suspected and we decided to perform scintigraphic imaging in order to verify this. Tc-99 scintigraphy with 5 mCI DTPA infusion was performed using a cannula after filling the abdominal cavity with dialysate solution. The result was that the activity in the peritoneal fluid passed into the left thoracic cavity at the early and specifically delayed sessions. In order to provide time for healing, peritoneal dialysis was postponed and hemodialysis thrice weekly was begun. After three weeks, CAPD was commenced with a lower amount of dialysate. The dialysate volume was increased gradually to the preoperative amount but the pleural effusion did not recur.
DIScUSSIoN
Patients with polycystic kidney disease (PKD) are more prone to pleuroperitoneal leakage as a complication of CAPD (2) . Increased intraabdominal pressure as well as weakness of connective tissues and also weakness of the diaphragm are considered to play a role together. Our patient had chronic kidney disease due to PKD but until the surgery she did not have any pleural effusion episode. Although data from the literature suggest most of the pleuroperitoneal leakage syndromes occur in the right side (1), our patient's fluid was left-sided despite the anatomic barrier created by the heart on the left side.
Patients under dialysis treatment frequently have pleural effusions due to hypervolemia. This complication can usually be treated by salt restriction and increasing the ultrafiltration volume (1). However if pleural effusion is a result of pleuroperitoneal leakage, increasing ultrafiltration by using higher osmolar and higher amounts of dialysate may increase the leakage. Symptoms can be mild but abrupt collection of large amounts of fluid can be life threatening. The presence of acute respiratory distress requires urgent drainage of fluid by thoracentesis. Symptomatic pleural effusion occurred in our patient about two months after the coronary by-pass operation. She presented with shortness of breath. On chest X-ray, there was some fluid on the left thoracal cavity. She was deoxygenated and thoracentesis for drainage of pleural fluid was performed quickly. After intervention, the collected fluid was analyzed in order to make a differential diagnosis. Light's criteria were used and the fluid was identified as transudate and was microscopically clear and the ADA test was also negative. The glucose concentration was 319 mg/dl in the pleural fluid sample although the serum level was 106 mg/ dl. It was decided to perform DTPA scintigraphy in order to determine if pleuroperitoneal leakage was the etiology.
Diagnosis can be made by computed tomography with intraperitoneal radiocontrast admixed with the dialysis fluid. Peritoneal scintigraphy is a also a reliable technique, as was the case in our patient. Tc-99m MAA, Tc-99m diethylene triamine pentaacetic acid (DTPA) and colloid can be used for diagnosis. In our patient, after suspecting pleuroperitoneal leakage, 
A) Early anterior and posterior→ Activity passing mildly into the left pleural zone in the images (arrow). B) Late (3rd hour) Activity pass that is progressively increasing confirms pleuroperitoneal leakage in the images.
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Kılıç İ et al: Scintigraphy in Pleuroperitoneal Leakage we investigated the biochemical properties of the serum and the pleural fluid that were obtained at the same time. The difference of more than 200 mg/dl in glucose concentrations between the samples was suggestive of pleuroperitoneal leakage. In order to confirm the connection between the pleural and peritoneal cavities we used the DTPA scintigraphy technique and verified the connection successfully ( Figure 1A,B) .
Temporary discontinuation of peritoneal dialysis and instead using hemodialysis is a preferred modality in the treatment of pleuroperitoneal leakage. This allows the peritoneum and related structures to rest and so ensure time for amelioration of the defects on the diaphragm (3). We switched to hemodialysis for three weeks. The signs and symptoms of pleural effusion completely disappeared. Even after turning back to CAPD with preoperative dialysate volume the condition did not recur. Three months after the time we had first shown the pleuroperitoneal leakage, we repeated the DTPA imaging and showed no activity passing through the diaphragm (Figure 2A,B) . So this has been the first case report in the literature showing the connection and after some time showing the recovery.
In conclusion, pleuroperitoneal leakage can be seen anytime due to congenital and diaphragmatic defects in peritoneal dialysis patients. It can be detected with radionuclide peritoneography and the resolution can be controlled easily with the same imaging technique. The clinician can consider using this technique as a very useful option while investigating peritoneal dialysis patients with pleural effusion.
